Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Lance Okeke

HIV/AIDS Medicine · Duke University

View

Dr. Raphael J. Landovitz

HIV/AIDS Medicine · UCLA

View

Dr. Aniruddha Hazra

HIV/AIDS Medicine · UCMC

View

Dr. Shital Patel

HIV/AIDS Medicine · BCM

View

Dr. Monica Gandhi

HIV/AIDS Medicine · UCSF

View

Dr. Ashwin Balagopal

HIV/AIDS Medicine · Johns Hopkins

View

Dr. Ofole Mgbako

HIV/AIDS Medicine · NYU Langone

View

Dr. Joshua Barocas

HIV/AIDS Medicine · CU Anschutz Medical Campus

View

Dr. Chris Beyrer

Global Health · Duke University

View

Dr. Keith Kaye

General ID · RU

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    ERDr. Elliot Raizes

    Dr. Elliot Raizes

    Infectious Disease · HIV & AIDS Medicine
    Positive Impact
    elliotraizes
    Atlanta, GA, USA
    Jul 11, 2026Journal Article

    Correlates of Dolutegravir Resistance in Low- and Middle-Income Countries: A Combined Analysis of Drug Resistance Surveys in Four Countries.

    ​

    Written by 1 Roon author & 13 others

    Via Clinical Infectious Diseases

    Research

    Virology Outcomes of Tenofovir-lamivudine-dolutegravir in Treatment-naïve and Virologically Suppressed Individuals Switching From an NNRTI-based Regimen: An Observational Analysis at 13 Sites

    2025

    Via Open Forum Infectious Diseases

    Research

    Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023

    2025

    Via Open Forum Infect Dis

    Research

    The promise of a "cure" for HIV: implications for the future of PEPFAR-supported HIV programmes

    2024

    Via J Int AIDS Soc

    Research

    High viral suppression rates among PLHIV on dolutegravir who had an initial episode of viral non-suppression in Uganda September 2020-July 2021

    2024

    Via PLoS One

    Research

    HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique

    2024

    Via BMC Infect Dis

    Research

    Beyond the 95s: What happens when uniform program targets are applied across a heterogenous HIV epidemic in Eastern and Southern Africa?

    2024

    Via PLOS Glob Public Health

    Research

    Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study

    2023

    Via Lancet HIV

    Research

    Resistance is common in paediatric patients failing ART in South Africa

    2023

    Via J Antimicrob Chemother

    Research

    Pharyngeal Co-Infections with Monkeypox Virus and Group A Streptococcus, United States, 2022

    2023

    Via Emerg Infect Dis

    Research

    Recommendations on data sharing in HIV drug resistance research

    2023

    Via PLoS Med

    Research

    PEPFAR's Role in Protecting and Leveraging HIV Services in the COVID-19 Response in Africa

    2022

    Via Curr HIV/AIDS Rep

    Research

    HIV-1 drug resistance mutations among individuals with low-level viraemia while taking combination ART in Botswana

    2022

    Via J Antimicrob Chemother

    Research

    Drug resistance and use of long-acting ART

    2022

    Via Lancet HIV

    Research

    Severe Monkeypox in Hospitalized Patients - United States, August 10-October 10, 2022

    2022

    Via MMWR Morb Mortal Wkly Rep